Invirsa submits investigational dry eye medication to FDA

By Becker's ASC in Becker's ASC Review, Channels, Featured
August 30, 2022

Invirsa has submitted an investigational new drug application to the FDA for INV-102, a medication intended to treat ocular conditions and dry eye caused by DNA damage.

Read the full post on Becker's ASC

Invirsa submits investigational dry eye medication to FDA

Becker's ASC

Most Recent